Although there is now strong evidence for the efficacy of low-radiation dose computed tomography in reducing lung cancer mortality, the challenge is to establish screening programmes that have the maximum impact on the disease. In screening programmes, participation rates are a major determinant of the success of the programme. Informed uptake, participation, and adherence (to successive screening rounds) determine the overall impact of the intervention by ensuring the maximum number of people at risk of the disease are screened regularly and therefore have the most chance of benefiting. Existing cancer screening programmes have taught us a great deal about methods that improve participation. Although evidence is emerging for the eff...
Successful implementation of low dose CT (LDCT) lung cancer screening, depends on a number of well-r...
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, ...
BACKGROUND: Targeted lung cancer screening is effective in reducing mortality by upwards of twenty p...
Although there is now strong evidence for the efficacy of low-radiation dose computed tomography in...
Question Screening with low dose computed tomography (LDCT) reduces lung-cancer mortality; however, ...
Funding: The LUNGSCOT study is funded by the Chief Scientists Office of the Scottish Government, ref...
Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available...
Introduction Despite strong evidence for the efficacy of low-radiation dose CT (LDCT) in reducing lu...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnos...
BACKGROUND: Participation in low-dose CT (LDCT) lung cancer screening offered in the trial context h...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
For decades, lung cancer has been the most common cancer in terms of both incidence and mortality. T...
This work was funded by the Chief Scientist Office (COBELT co-design study).Background: Lung cancer ...
Background Participation in low-dose CT (LDCT) lung cancer screening offered in the trial context ha...
Successful implementation of low dose CT (LDCT) lung cancer screening, depends on a number of well-r...
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, ...
BACKGROUND: Targeted lung cancer screening is effective in reducing mortality by upwards of twenty p...
Although there is now strong evidence for the efficacy of low-radiation dose computed tomography in...
Question Screening with low dose computed tomography (LDCT) reduces lung-cancer mortality; however, ...
Funding: The LUNGSCOT study is funded by the Chief Scientists Office of the Scottish Government, ref...
Lung cancer is the leading cause of cancer deaths in Europe and around the world. Although available...
Introduction Despite strong evidence for the efficacy of low-radiation dose CT (LDCT) in reducing lu...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnos...
BACKGROUND: Participation in low-dose CT (LDCT) lung cancer screening offered in the trial context h...
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors...
For decades, lung cancer has been the most common cancer in terms of both incidence and mortality. T...
This work was funded by the Chief Scientist Office (COBELT co-design study).Background: Lung cancer ...
Background Participation in low-dose CT (LDCT) lung cancer screening offered in the trial context ha...
Successful implementation of low dose CT (LDCT) lung cancer screening, depends on a number of well-r...
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, ...
BACKGROUND: Targeted lung cancer screening is effective in reducing mortality by upwards of twenty p...